Global Cell and Gene Therapy Bioassay Services Supply, Demand and Key Producers, 2024-2030

Description

The global Cell and Gene Therapy Bioassay Services market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies the global Cell and Gene Therapy Bioassay Services demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell and Gene Therapy Bioassay Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell and Gene Therapy Bioassay Services that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cell and Gene Therapy Bioassay Services total market, 2019-2030, (USD Million)
Global Cell and Gene Therapy Bioassay Services total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Cell and Gene Therapy Bioassay Services total market, key domestic companies and share, (USD Million)
Global Cell and Gene Therapy Bioassay Services revenue by player and market share 2019-2024, (USD Million)
Global Cell and Gene Therapy Bioassay Services total market by Type, CAGR, 2019-2030, (USD Million)
Global Cell and Gene Therapy Bioassay Services total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Cell and Gene Therapy Bioassay Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Anabiotec, Ccrm, Nexelis, Pacific Biolabs, Ppd Laboratories, Intertek Pharmaceutical Services, Lonza, Porton Biopharma Ltd and Wuxi Advanced Therapies, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell and Gene Therapy Bioassay Services market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Cell and Gene Therapy Bioassay Services Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cell and Gene Therapy Bioassay Services Market, Segmentation by Type
    Cell Therapy
    Gene Therapy

Global Cell and Gene Therapy Bioassay Services Market, Segmentation by Application
    Pharmaceutical Company
    Biotechnology
    Others
    Mucopolysaccharidosis (MPS) Type lV A
    Others

Companies Profiled:
    Anabiotec
    Ccrm
    Nexelis
    Pacific Biolabs
    Ppd Laboratories
    Intertek Pharmaceutical Services
    Lonza
    Porton Biopharma Ltd
    Wuxi Advanced Therapies
    Avomeen
    Charles River Laboratories
    Absorption Systems
    Bioagilytix Labs
    Catalent Inc
    Svar Life Science Ab

Key Questions Answered
1. How big is the global Cell and Gene Therapy Bioassay Services market?
2. What is the demand of the global Cell and Gene Therapy Bioassay Services market?
3. What is the year over year growth of the global Cell and Gene Therapy Bioassay Services market?
4. What is the total value of the global Cell and Gene Therapy Bioassay Services market?
5. Who are the major players in the global Cell and Gene Therapy Bioassay Services market?

Table of Contents

1 Supply Summary
    1.1 Cell and Gene Therapy Bioassay Services Introduction
    1.2 World Cell and Gene Therapy Bioassay Services Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Cell and Gene Therapy Bioassay Services Total Market by Region (by Headquarter Location)
        1.3.1 World Cell and Gene Therapy Bioassay Services Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Cell and Gene Therapy Bioassay Services Market Size (2019-2030)
        1.3.3 China Cell and Gene Therapy Bioassay Services Market Size (2019-2030)
        1.3.4 Europe Cell and Gene Therapy Bioassay Services Market Size (2019-2030)
        1.3.5 Japan Cell and Gene Therapy Bioassay Services Market Size (2019-2030)
        1.3.6 South Korea Cell and Gene Therapy Bioassay Services Market Size (2019-2030)
        1.3.7 ASEAN Cell and Gene Therapy Bioassay Services Market Size (2019-2030)
        1.3.8 India Cell and Gene Therapy Bioassay Services Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cell and Gene Therapy Bioassay Services Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Cell and Gene Therapy Bioassay Services Major Market Trends

2 Demand Summary
    2.1 World Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030)
    2.2 World Cell and Gene Therapy Bioassay Services Consumption Value by Region
        2.2.1 World Cell and Gene Therapy Bioassay Services Consumption Value by Region (2019-2024)
        2.2.2 World Cell and Gene Therapy Bioassay Services Consumption Value Forecast by Region (2025-2030)
    2.3 United States Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030)
    2.4 China Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030)
    2.5 Europe Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030)
    2.6 Japan Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030)
    2.7 South Korea Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030)
    2.8 ASEAN Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030)
    2.9 India Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030)

3 World Cell and Gene Therapy Bioassay Services Companies Competitive Analysis
    3.1 World Cell and Gene Therapy Bioassay Services Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cell and Gene Therapy Bioassay Services Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cell and Gene Therapy Bioassay Services in 2023
        3.2.3 Global Concentration Ratios (CR8) for Cell and Gene Therapy Bioassay Services in 2023
    3.3 Cell and Gene Therapy Bioassay Services Company Evaluation Quadrant
    3.4 Cell and Gene Therapy Bioassay Services Market: Overall Company Footprint Analysis
        3.4.1 Cell and Gene Therapy Bioassay Services Market: Region Footprint
        3.4.2 Cell and Gene Therapy Bioassay Services Market: Company Product Type Footprint
        3.4.3 Cell and Gene Therapy Bioassay Services Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Cell and Gene Therapy Bioassay Services Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cell and Gene Therapy Bioassay Services Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Cell and Gene Therapy Bioassay Services Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Cell and Gene Therapy Bioassay Services Consumption Value Comparison
        4.2.1 United States VS China: Cell and Gene Therapy Bioassay Services Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Cell and Gene Therapy Bioassay Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Cell and Gene Therapy Bioassay Services Companies and Market Share, 2019-2024
        4.3.1 United States Based Cell and Gene Therapy Bioassay Services Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cell and Gene Therapy Bioassay Services Revenue, (2019-2024)
    4.4 China Based Companies Cell and Gene Therapy Bioassay Services Revenue and Market Share, 2019-2024
        4.4.1 China Based Cell and Gene Therapy Bioassay Services Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cell and Gene Therapy Bioassay Services Revenue, (2019-2024)
    4.5 Rest of World Based Cell and Gene Therapy Bioassay Services Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Cell and Gene Therapy Bioassay Services Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Cell and Gene Therapy Bioassay Services Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Cell and Gene Therapy Bioassay Services Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Cell Therapy
        5.2.2 Gene Therapy
    5.3 Market Segment by Type
        5.3.1 World Cell and Gene Therapy Bioassay Services Market Size by Type (2019-2024)
        5.3.2 World Cell and Gene Therapy Bioassay Services Market Size by Type (2025-2030)
        5.3.3 World Cell and Gene Therapy Bioassay Services Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Cell and Gene Therapy Bioassay Services Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Pharmaceutical Company
        6.2.2 Biotechnology
        6.2.3 Others
        6.2.4 Mucopolysaccharidosis (MPS) Type lV A
        6.2.5 Mucopolysaccharidosis (MPS) Type lV A
    6.3 Market Segment by Application
        6.3.1 World Cell and Gene Therapy Bioassay Services Market Size by Application (2019-2024)
        6.3.2 World Cell and Gene Therapy Bioassay Services Market Size by Application (2025-2030)
        6.3.3 World Cell and Gene Therapy Bioassay Services Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Anabiotec
        7.1.1 Anabiotec Details
        7.1.2 Anabiotec Major Business
        7.1.3 Anabiotec Cell and Gene Therapy Bioassay Services Product and Services
        7.1.4 Anabiotec Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Anabiotec Recent Developments/Updates
        7.1.6 Anabiotec Competitive Strengths & Weaknesses
    7.2 Ccrm
        7.2.1 Ccrm Details
        7.2.2 Ccrm Major Business
        7.2.3 Ccrm Cell and Gene Therapy Bioassay Services Product and Services
        7.2.4 Ccrm Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Ccrm Recent Developments/Updates
        7.2.6 Ccrm Competitive Strengths & Weaknesses
    7.3 Nexelis
        7.3.1 Nexelis Details
        7.3.2 Nexelis Major Business
        7.3.3 Nexelis Cell and Gene Therapy Bioassay Services Product and Services
        7.3.4 Nexelis Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Nexelis Recent Developments/Updates
        7.3.6 Nexelis Competitive Strengths & Weaknesses
    7.4 Pacific Biolabs
        7.4.1 Pacific Biolabs Details
        7.4.2 Pacific Biolabs Major Business
        7.4.3 Pacific Biolabs Cell and Gene Therapy Bioassay Services Product and Services
        7.4.4 Pacific Biolabs Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Pacific Biolabs Recent Developments/Updates
        7.4.6 Pacific Biolabs Competitive Strengths & Weaknesses
    7.5 Ppd Laboratories
        7.5.1 Ppd Laboratories Details
        7.5.2 Ppd Laboratories Major Business
        7.5.3 Ppd Laboratories Cell and Gene Therapy Bioassay Services Product and Services
        7.5.4 Ppd Laboratories Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Ppd Laboratories Recent Developments/Updates
        7.5.6 Ppd Laboratories Competitive Strengths & Weaknesses
    7.6 Intertek Pharmaceutical Services
        7.6.1 Intertek Pharmaceutical Services Details
        7.6.2 Intertek Pharmaceutical Services Major Business
        7.6.3 Intertek Pharmaceutical Services Cell and Gene Therapy Bioassay Services Product and Services
        7.6.4 Intertek Pharmaceutical Services Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Intertek Pharmaceutical Services Recent Developments/Updates
        7.6.6 Intertek Pharmaceutical Services Competitive Strengths & Weaknesses
    7.7 Lonza
        7.7.1 Lonza Details
        7.7.2 Lonza Major Business
        7.7.3 Lonza Cell and Gene Therapy Bioassay Services Product and Services
        7.7.4 Lonza Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Lonza Recent Developments/Updates
        7.7.6 Lonza Competitive Strengths & Weaknesses
    7.8 Porton Biopharma Ltd
        7.8.1 Porton Biopharma Ltd Details
        7.8.2 Porton Biopharma Ltd Major Business
        7.8.3 Porton Biopharma Ltd Cell and Gene Therapy Bioassay Services Product and Services
        7.8.4 Porton Biopharma Ltd Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Porton Biopharma Ltd Recent Developments/Updates
        7.8.6 Porton Biopharma Ltd Competitive Strengths & Weaknesses
    7.9 Wuxi Advanced Therapies
        7.9.1 Wuxi Advanced Therapies Details
        7.9.2 Wuxi Advanced Therapies Major Business
        7.9.3 Wuxi Advanced Therapies Cell and Gene Therapy Bioassay Services Product and Services
        7.9.4 Wuxi Advanced Therapies Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Wuxi Advanced Therapies Recent Developments/Updates
        7.9.6 Wuxi Advanced Therapies Competitive Strengths & Weaknesses
    7.10 Avomeen
        7.10.1 Avomeen Details
        7.10.2 Avomeen Major Business
        7.10.3 Avomeen Cell and Gene Therapy Bioassay Services Product and Services
        7.10.4 Avomeen Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Avomeen Recent Developments/Updates
        7.10.6 Avomeen Competitive Strengths & Weaknesses
    7.11 Charles River Laboratories
        7.11.1 Charles River Laboratories Details
        7.11.2 Charles River Laboratories Major Business
        7.11.3 Charles River Laboratories Cell and Gene Therapy Bioassay Services Product and Services
        7.11.4 Charles River Laboratories Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Charles River Laboratories Recent Developments/Updates
        7.11.6 Charles River Laboratories Competitive Strengths & Weaknesses
    7.12 Absorption Systems
        7.12.1 Absorption Systems Details
        7.12.2 Absorption Systems Major Business
        7.12.3 Absorption Systems Cell and Gene Therapy Bioassay Services Product and Services
        7.12.4 Absorption Systems Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Absorption Systems Recent Developments/Updates
        7.12.6 Absorption Systems Competitive Strengths & Weaknesses
    7.13 Bioagilytix Labs
        7.13.1 Bioagilytix Labs Details
        7.13.2 Bioagilytix Labs Major Business
        7.13.3 Bioagilytix Labs Cell and Gene Therapy Bioassay Services Product and Services
        7.13.4 Bioagilytix Labs Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Bioagilytix Labs Recent Developments/Updates
        7.13.6 Bioagilytix Labs Competitive Strengths & Weaknesses
    7.14 Catalent Inc
        7.14.1 Catalent Inc Details
        7.14.2 Catalent Inc Major Business
        7.14.3 Catalent Inc Cell and Gene Therapy Bioassay Services Product and Services
        7.14.4 Catalent Inc Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Catalent Inc Recent Developments/Updates
        7.14.6 Catalent Inc Competitive Strengths & Weaknesses
    7.15 Svar Life Science Ab
        7.15.1 Svar Life Science Ab Details
        7.15.2 Svar Life Science Ab Major Business
        7.15.3 Svar Life Science Ab Cell and Gene Therapy Bioassay Services Product and Services
        7.15.4 Svar Life Science Ab Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Svar Life Science Ab Recent Developments/Updates
        7.15.6 Svar Life Science Ab Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cell and Gene Therapy Bioassay Services Industry Chain
    8.2 Cell and Gene Therapy Bioassay Services Upstream Analysis
    8.3 Cell and Gene Therapy Bioassay Services Midstream Analysis
    8.4 Cell and Gene Therapy Bioassay Services Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Cell and Gene Therapy Bioassay Services Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Cell and Gene Therapy Bioassay Services Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Cell and Gene Therapy Bioassay Services Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Cell and Gene Therapy Bioassay Services Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Cell and Gene Therapy Bioassay Services Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Cell and Gene Therapy Bioassay Services Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Cell and Gene Therapy Bioassay Services Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Cell and Gene Therapy Bioassay Services Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Cell and Gene Therapy Bioassay Services Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Cell and Gene Therapy Bioassay Services Players in 2023
    Table 12. World Cell and Gene Therapy Bioassay Services Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Cell and Gene Therapy Bioassay Services Company Evaluation Quadrant
    Table 14. Head Office of Key Cell and Gene Therapy Bioassay Services Player
    Table 15. Cell and Gene Therapy Bioassay Services Market: Company Product Type Footprint
    Table 16. Cell and Gene Therapy Bioassay Services Market: Company Product Application Footprint
    Table 17. Cell and Gene Therapy Bioassay Services Mergers & Acquisitions Activity
    Table 18. United States VS China Cell and Gene Therapy Bioassay Services Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Cell and Gene Therapy Bioassay Services Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Cell and Gene Therapy Bioassay Services Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Cell and Gene Therapy Bioassay Services Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Cell and Gene Therapy Bioassay Services Revenue Market Share (2019-2024)
    Table 23. China Based Cell and Gene Therapy Bioassay Services Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Cell and Gene Therapy Bioassay Services Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Cell and Gene Therapy Bioassay Services Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Cell and Gene Therapy Bioassay Services Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Cell and Gene Therapy Bioassay Services Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Cell and Gene Therapy Bioassay Services Revenue Market Share (2019-2024)
    Table 29. World Cell and Gene Therapy Bioassay Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Cell and Gene Therapy Bioassay Services Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Cell and Gene Therapy Bioassay Services Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Cell and Gene Therapy Bioassay Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Cell and Gene Therapy Bioassay Services Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Cell and Gene Therapy Bioassay Services Market Size by Application (2025-2030) & (USD Million)
    Table 35. Anabiotec Basic Information, Area Served and Competitors
    Table 36. Anabiotec Major Business
    Table 37. Anabiotec Cell and Gene Therapy Bioassay Services Product and Services
    Table 38. Anabiotec Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Anabiotec Recent Developments/Updates
    Table 40. Anabiotec Competitive Strengths & Weaknesses
    Table 41. Ccrm Basic Information, Area Served and Competitors
    Table 42. Ccrm Major Business
    Table 43. Ccrm Cell and Gene Therapy Bioassay Services Product and Services
    Table 44. Ccrm Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Ccrm Recent Developments/Updates
    Table 46. Ccrm Competitive Strengths & Weaknesses
    Table 47. Nexelis Basic Information, Area Served and Competitors
    Table 48. Nexelis Major Business
    Table 49. Nexelis Cell and Gene Therapy Bioassay Services Product and Services
    Table 50. Nexelis Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Nexelis Recent Developments/Updates
    Table 52. Nexelis Competitive Strengths & Weaknesses
    Table 53. Pacific Biolabs Basic Information, Area Served and Competitors
    Table 54. Pacific Biolabs Major Business
    Table 55. Pacific Biolabs Cell and Gene Therapy Bioassay Services Product and Services
    Table 56. Pacific Biolabs Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Pacific Biolabs Recent Developments/Updates
    Table 58. Pacific Biolabs Competitive Strengths & Weaknesses
    Table 59. Ppd Laboratories Basic Information, Area Served and Competitors
    Table 60. Ppd Laboratories Major Business
    Table 61. Ppd Laboratories Cell and Gene Therapy Bioassay Services Product and Services
    Table 62. Ppd Laboratories Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Ppd Laboratories Recent Developments/Updates
    Table 64. Ppd Laboratories Competitive Strengths & Weaknesses
    Table 65. Intertek Pharmaceutical Services Basic Information, Area Served and Competitors
    Table 66. Intertek Pharmaceutical Services Major Business
    Table 67. Intertek Pharmaceutical Services Cell and Gene Therapy Bioassay Services Product and Services
    Table 68. Intertek Pharmaceutical Services Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Intertek Pharmaceutical Services Recent Developments/Updates
    Table 70. Intertek Pharmaceutical Services Competitive Strengths & Weaknesses
    Table 71. Lonza Basic Information, Area Served and Competitors
    Table 72. Lonza Major Business
    Table 73. Lonza Cell and Gene Therapy Bioassay Services Product and Services
    Table 74. Lonza Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Lonza Recent Developments/Updates
    Table 76. Lonza Competitive Strengths & Weaknesses
    Table 77. Porton Biopharma Ltd Basic Information, Area Served and Competitors
    Table 78. Porton Biopharma Ltd Major Business
    Table 79. Porton Biopharma Ltd Cell and Gene Therapy Bioassay Services Product and Services
    Table 80. Porton Biopharma Ltd Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Porton Biopharma Ltd Recent Developments/Updates
    Table 82. Porton Biopharma Ltd Competitive Strengths & Weaknesses
    Table 83. Wuxi Advanced Therapies Basic Information, Area Served and Competitors
    Table 84. Wuxi Advanced Therapies Major Business
    Table 85. Wuxi Advanced Therapies Cell and Gene Therapy Bioassay Services Product and Services
    Table 86. Wuxi Advanced Therapies Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Wuxi Advanced Therapies Recent Developments/Updates
    Table 88. Wuxi Advanced Therapies Competitive Strengths & Weaknesses
    Table 89. Avomeen Basic Information, Area Served and Competitors
    Table 90. Avomeen Major Business
    Table 91. Avomeen Cell and Gene Therapy Bioassay Services Product and Services
    Table 92. Avomeen Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Avomeen Recent Developments/Updates
    Table 94. Avomeen Competitive Strengths & Weaknesses
    Table 95. Charles River Laboratories Basic Information, Area Served and Competitors
    Table 96. Charles River Laboratories Major Business
    Table 97. Charles River Laboratories Cell and Gene Therapy Bioassay Services Product and Services
    Table 98. Charles River Laboratories Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Charles River Laboratories Recent Developments/Updates
    Table 100. Charles River Laboratories Competitive Strengths & Weaknesses
    Table 101. Absorption Systems Basic Information, Area Served and Competitors
    Table 102. Absorption Systems Major Business
    Table 103. Absorption Systems Cell and Gene Therapy Bioassay Services Product and Services
    Table 104. Absorption Systems Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. Absorption Systems Recent Developments/Updates
    Table 106. Absorption Systems Competitive Strengths & Weaknesses
    Table 107. Bioagilytix Labs Basic Information, Area Served and Competitors
    Table 108. Bioagilytix Labs Major Business
    Table 109. Bioagilytix Labs Cell and Gene Therapy Bioassay Services Product and Services
    Table 110. Bioagilytix Labs Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Bioagilytix Labs Recent Developments/Updates
    Table 112. Bioagilytix Labs Competitive Strengths & Weaknesses
    Table 113. Catalent Inc Basic Information, Area Served and Competitors
    Table 114. Catalent Inc Major Business
    Table 115. Catalent Inc Cell and Gene Therapy Bioassay Services Product and Services
    Table 116. Catalent Inc Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 117. Catalent Inc Recent Developments/Updates
    Table 118. Svar Life Science Ab Basic Information, Area Served and Competitors
    Table 119. Svar Life Science Ab Major Business
    Table 120. Svar Life Science Ab Cell and Gene Therapy Bioassay Services Product and Services
    Table 121. Svar Life Science Ab Cell and Gene Therapy Bioassay Services Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 122. Global Key Players of Cell and Gene Therapy Bioassay Services Upstream (Raw Materials)
    Table 123. Cell and Gene Therapy Bioassay Services Typical Customers
List of Figure
    Figure 1. Cell and Gene Therapy Bioassay Services Picture
    Figure 2. World Cell and Gene Therapy Bioassay Services Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Cell and Gene Therapy Bioassay Services Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Cell and Gene Therapy Bioassay Services Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Cell and Gene Therapy Bioassay Services Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Cell and Gene Therapy Bioassay Services Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Cell and Gene Therapy Bioassay Services Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Cell and Gene Therapy Bioassay Services Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Cell and Gene Therapy Bioassay Services Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Cell and Gene Therapy Bioassay Services Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Cell and Gene Therapy Bioassay Services Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Cell and Gene Therapy Bioassay Services Revenue (2019-2030) & (USD Million)
    Figure 13. Cell and Gene Therapy Bioassay Services Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Cell and Gene Therapy Bioassay Services Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Cell and Gene Therapy Bioassay Services Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Cell and Gene Therapy Bioassay Services by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Cell and Gene Therapy Bioassay Services Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Cell and Gene Therapy Bioassay Services Markets in 2023
    Figure 27. United States VS China: Cell and Gene Therapy Bioassay Services Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Cell and Gene Therapy Bioassay Services Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Cell and Gene Therapy Bioassay Services Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Cell and Gene Therapy Bioassay Services Market Size Market Share by Type in 2023
    Figure 31. Cell Therapy
    Figure 32. Gene Therapy
    Figure 33. World Cell and Gene Therapy Bioassay Services Market Size Market Share by Type (2019-2030)
    Figure 34. World Cell and Gene Therapy Bioassay Services Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 35. World Cell and Gene Therapy Bioassay Services Market Size Market Share by Application in 2023
    Figure 36. Pharmaceutical Company
    Figure 37. Biotechnology
    Figure 38. Others
    Figure 39. Mucopolysaccharidosis (MPS) Type lV A
    Figure 40. Others
    Figure 41. Cell and Gene Therapy Bioassay Services Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Companies Mentioned

Anabiotec
Ccrm
Nexelis
Pacific Biolabs
Ppd Laboratories
Intertek Pharmaceutical Services
Lonza
Porton Biopharma Ltd
Wuxi Advanced Therapies
Avomeen
Charles River Laboratories
Absorption Systems
Bioagilytix Labs
Catalent Inc
Svar Life Science Ab